Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.39 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11722894 | 0.81 | MEN1 (0.48) | TSHRKMT2AMEN1SMN1; SMN2ALDH1A1 | |
| SCHEMBL11505098 | 0.77 | ALDH1A1 (0.44) | TSHRTP53KMT2AMEN1MAPK1 | |
| SCHEMBL24393532 | 0.77 | CA1 (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11100795 | 0.76 | TP53 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11312675 | 0.74 | ALDH1A1 (0.64) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1857458 | 0.74 | CA12 (0.42) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11108362 | 0.73 | TP53 (0.70) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7847544 | 0.73 | TP53 (0.38) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11312605 | 0.71 | TDP1 (0.62) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1856414 | 0.70 | ALDH1A1 (0.50) | TSHRKMT2AMEN1ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220144760-A1 | METHOD OF PRODUCING CARBONYL COMPOUND AND FLOW TYPE REACTION SYSTEM OF PRODUCING CARBONYL COMPOUND | FUJIFILM CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20220135517-A1 | METHOD OF PRODUCING CARBONYL COMPOUND AND FLOW TYPE REACTION SYSTEM OF PRODUCING CARBONYL COMPOUND | FUJIFILM CORPORATION (JP) | 2022-05-05 | — | — | US | disclosed |
| WO-2021033505-A1 | METHOD FOR PRODUCING CARBONYL COMPOUND AND FLOW REACTION SYSTEM USED FOR PRODUCTION OF CARBONYL COMPOUND | 富士フイルム株式会社 | 2021-02-25 | — | — | WO | disclosed |
| WO-2021033504-A1 | METHOD FOR PRODUCING CARBONYL COMPOUND AND FLOW REACTION SYSTEM USED FOR PRODUCTION OF CARBONYL COMPOUND | 富士フイルム株式会社 | 2021-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220135517-A1 | METHOD OF PRODUCING CARBONYL COMPOUND AND FLOW TYPE REACTION SYSTEM OF PRODUCING CARBONYL COMPOUND | PARG, PTGIS, MT-ATP8 | CA12 3217/4885CA1 2542/4885CA2 1471/4885 |
| US-20220144760-A1 | METHOD OF PRODUCING CARBONYL COMPOUND AND FLOW TYPE REACTION SYSTEM OF PRODUCING CARBONYL COMPOUND | NOXO1, MT-CO2, MT-ATP8 | CA12 2367/4885CA1 1274/4885CA2 370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.